Menu
Back to Journals » Clinical, Cosmetic and Investigational Dermatology » Volume 15
A Prospective, Open-Label Study to Evaluate the Impact of VYC-12L Injection on Skin Quality Attributes in Healthy Volunteers [Corrigendum]
Authors Safa M , Natalizio A, Hee CK
Received 31 March 2022
Accepted for publication 31 March 2022
Published 7 April 2022 Volume 2022:15 Pages 585—586
Safa M, Natalizio A, Hee CK. Clin Cosmet Investig Dermatol. 2022;15:411-426.
The authors have advised there is an error in Table 2 on page 417. The value “0.3 (1.3)” in the Probe S hydration rate: A.U. (SEM) row for Moisturemeter®, Month 1, VYC-12L column should read “0.8 (1.3)”.
The authors apologize for this error and advise it does not affect the results of the paper.
© 2022 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.